Janus Henderson Group’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-177,532
Closed -$32.6M 2250
2021
Q2
$32.6M Sell
177,532
-465,289
-72% -$85.5M 0.01% 668
2021
Q1
$98.3M Sell
642,821
-2,054,365
-76% -$314M 0.04% 376
2020
Q4
$421M Buy
2,697,186
+1,149,833
+74% +$180M 0.2% 124
2020
Q3
$177M Buy
1,547,353
+1,313,698
+562% +$150M 0.09% 223
2020
Q2
$26.2M Buy
233,655
+79,811
+52% +$8.96M 0.01% 643
2020
Q1
$13.8M Buy
153,844
+77,541
+102% +$6.96M 0.01% 760
2019
Q4
$8.25M Sell
76,303
-91,599
-55% -$9.91M ﹤0.01% 974
2019
Q3
$16.4M Sell
167,902
-457,629
-73% -$44.8M 0.01% 868
2019
Q2
$81.9M Sell
625,531
-699,824
-53% -$91.7M 0.04% 434
2019
Q1
$179M Buy
1,325,355
+303,359
+30% +$41M 0.1% 238
2018
Q4
$99.5M Buy
1,021,996
+36,372
+4% +$3.54M 0.06% 346
2018
Q3
$137M Sell
985,624
-75,765
-7% -$10.5M 0.07% 320
2018
Q2
$132M Sell
1,061,389
-140,040
-12% -$17.4M 0.08% 311
2018
Q1
$134M Sell
1,201,429
-104,263
-8% -$11.6M 0.08% 298
2017
Q4
$156M Buy
1,305,692
+270,229
+26% +$32.3M 0.09% 251
2017
Q3
$145M Sell
1,035,463
-110,455
-10% -$15.5M 0.09% 265
2017
Q2
$139M Buy
1,145,918
+1,082,171
+1,698% +$132M 0.09% 270
2017
Q1
$7.73M Sell
63,747
-1,561
-2% -$189K 0.05% 309
2016
Q4
$7.99M Sell
65,308
-87
-0.1% -$10.6K 0.06% 310
2016
Q3
$8.01M Sell
65,395
-3,501
-5% -$429K 0.06% 294
2016
Q2
$8.05M Sell
68,896
-4,635
-6% -$541K 0.07% 281
2016
Q1
$10.2M Buy
73,531
+42,741
+139% +$5.95M 0.08% 258
2015
Q4
$5.87M Sell
30,790
-12
-0% -$2.29K 0.05% 320
2015
Q3
$4.82M Buy
30,802
+2,833
+10% +$443K 0.04% 351
2015
Q2
$5.05M Sell
27,969
-244
-0.9% -$44.1K 0.04% 360
2015
Q1
$4.89M Hold
28,213
0.04% 370
2014
Q4
$5.22M Hold
28,213
0.04% 362
2014
Q3
$4.68M Hold
28,213
0.04% 281
2014
Q2
$4.41M Hold
28,213
0.04% 291
2014
Q1
$4.29M Buy
28,213
+6,113
+28% +$930K 0.04% 301
2013
Q4
$2.94M Hold
22,100
0.03% 343
2013
Q3
$2.57M Sell
22,100
-965
-4% -$112K 0.03% 351
2013
Q2
$2.21M Buy
+23,065
New +$2.21M 0.03% 366